PhaseBio Pharmaceuticals, Inc. (PHAS)
PhaseBio Pharmaceuticals, Inc. (PHAS)
$5.37 USD
Updated Sep 13 12:00am
Add PHAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
PHAS Stock Chart More Charts
PHAS Price/Volume Stats
| Current price | $5.37 |
| Prev. close | $5.13 |
| Day low | $5.08 |
| Day high | $5.44 |
| 50-day MA | $8.37 |
| 200-day MA | $7.76 |
| 52-week high | $16.65 |
| 52-week low | $2.55 |
| Volume | 270,200 |
| Avg. volume | 263,057 |
| Dividend yield | N/A |
| Market Cap | 154.11M |
PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio
PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
Top Stories View All
101 Fresh Upgrades to Start the Week
2900 or 3100: Which Comes Next?
Best & Worst Performing Stock Industries for September 13, 2019
Best & Worst Performing Small Cap Stocks for September 13, 2019
Best & Worst Performing Large Cap Stocks for September 13, 2019
View All Top Stories
Loading social stream, please wait...